Virtu KCG Holdings’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | $110K | Buy |
11,314
+3,588
| +46% | +$34.9K | ﹤0.01% | 2375 |
|
2017
Q1 | $187K | Buy |
7,726
+4,302
| +126% | +$104K | 0.01% | 2453 |
|
2016
Q4 | $110K | Buy |
+3,424
| New | +$110K | ﹤0.01% | 2859 |
|
2016
Q3 | – | Sell |
-9,142
| Closed | -$388K | – | 3716 |
|
2016
Q2 | $388K | Buy |
9,142
+5,418
| +145% | +$230K | 0.01% | 1600 |
|
2016
Q1 | $245K | Buy |
+3,724
| New | +$245K | 0.01% | 1882 |
|
2015
Q3 | – | Sell |
-2,851
| Closed | -$277K | – | 3556 |
|
2015
Q2 | $277K | Buy |
+2,851
| New | +$277K | 0.01% | 1756 |
|
2015
Q1 | – | Sell |
-1,786
| Closed | -$159K | – | 3408 |
|
2014
Q4 | $159K | Buy |
+1,786
| New | +$159K | ﹤0.01% | 2149 |
|
2014
Q2 | – | Sell |
-1,983
| Closed | -$79K | – | 3082 |
|
2014
Q1 | $79K | Buy |
+1,983
| New | +$79K | ﹤0.01% | 2075 |
|
2013
Q4 | – | Sell |
-2,337
| Closed | -$70K | – | 3177 |
|
2013
Q3 | $70K | Buy |
+2,337
| New | +$70K | ﹤0.01% | 2352 |
|